Meeting
2024 ASCO Annual Meeting
Impact of HER2 low status on genomic signatures in triple negative breast cancer (TNBC).
Authors
Melissa Taylor
Yale New Haven Hospital, New Haven, CT
Melissa Taylor , Shilpa Reddy , Prashanth Ashok Kumar , Dana Hariri , Ethan Sokol , Smruthy Sivakumar , Julia Quintanilha , Dean Pavlick , Mia Alyce Levy , Jeffrey S. Ross , Maryam B. Lustberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Triple-Negative
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 1092)
DOI
10.1200/JCO.2024.42.16_suppl.1092
Abstract #
1092
Poster Bd #
70
Abstract Disclosures
Similar Posters
First Author: Neal A. Fischbach
Poster
2022 ASCO Genitourinary Cancers Symposium
Impact of PD-L1 expression on conventional urothelial bladder carcinoma (UBC) genomic alteration (GA) profile.
First Author: Petros Grivas
Poster
2021 ASCO Annual Meeting
HER2 in uterine serous carcinoma: Testing platforms and implications for targeted therapy.
First Author: Tenley Klc
Poster
2020 ASCO Virtual Scientific Program
Genomic profiling of breast cancer brain metastases reveals targetable alterations.
First Author: Sheheryar Kairas Kabraji